SEC 13F Intelligence

Managers / Q4 2021 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$773M
Q4 2021
Positions
44
Filings on Record
37
2019–present window
Filed
Feb 14, 2022
original filing

Summary

Bridger Management, LLC reported $773M in U.S.-listed holdings across 44 positions for Q4 2021.

Its largest position, GDDY, represents 8.0% of the portfolio.

Compared with Q3 2021, the fund opened 6 new positions and exited 8.

Portfolio Metrics

Turnover
+16.3%
vs prior filed quarter
Top-10 Concentration
+52.8%
share of reported value
Largest Position
+8.0%
Godaddy
New / Exited
6 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 79.8%Other: 15.6%ADR: 4.0%ETP: 0.6%Equity WRT: 0.1%
  • Common Stock · 79.8% · $617M
  • Other · 15.6% · $121M
  • ADR · 4.0% · $31M
  • ETP · 0.6% · $5M
  • Equity WRT · 0.1% · $537,000

Quarter-over-Quarter Changes full breakdown →

vs Q3 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
IRTCIRHYTHM TECHNOLOGIES INCNEW+309.1K309.1K+$36M$36M
AIRSAIRSCULPT TECHNOLOGIES INCNEW+1.68M1.68M+$29M$29M
OLAPLEX HLDGS INCNEW+504.4K504.4K+$15M$15M
VRTXVERTEX PHARMACEUTICALS INCNEW+59.4K59.4K+$13M$13M
MSOSADVISORSHARES TRNEW+176.5K176.5K+$5M$5M
DMTKQDERMTECH INCNEW+226.1K226.1K+$4M$4M
NAUTNAUTILUS BIOTECHNOLOGY INCADDED+163.0K289.0K+$723,000$1M
FTDRFRONTDOOR INCSOLD OUT−596.8K0−$25M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2021

42 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1GDDYGODADDY INChistory →CL A8.03%$62M731.8K
2UBERUBER TECHNOLOGIES INChistory →COM5.51%$43M1.02M
3DWDMORGAN STANLEYhistory →COM NEW5.29%$41M416.4K
4VRSNVERISIGN INChistory →COM5.21%$40M158.7K
5CZRCAESARS ENTERTAINMENT INC NEhistory →COM5.17%$40M427.4K
6ROSTROSS STORES INChistory →COM5.15%$40M348.7K
7CLARIVATE PLCORD SHS4.86%$38M1.60M
8IRTCIRHYTHM TECHNOLOGIES INChistory →COM4.70%$36M309.1K
9CNCCENTENE CORP DELhistory →COM4.48%$35M420.4K
10CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A4.44%$34M52.7K
11NTRANATERA INChistory →COM3.78%$29M313.3K
12AIRSAIRSCULPT TECHNOLOGIES INChistory →COM3.73%$29M1.68M
13ALCON AGORD SHS3.09%$24M274.2K
14LKQ1LKQ CORPhistory →COM3.07%$24M395.6K
15ETSYETSY INChistory →COM2.77%$21M97.8K
16POSTPOST HLDGS INChistory →COM2.66%$21M182.6K
17GDSGDS HLDGS LTDhistory →SPONSORED ADS2.41%$19M395.0K
18HCAHCA HEALTHCARE INChistory →COM2.24%$17M67.5K
19SKIN2EURTHE BEAUTY HEALTH COMPANYhistory →COM CL A2.19%$17M700.3K
20OLAPLEX HLDGS INCCOM1.90%$15M504.4K
21DGDOLLAR GEN CORP NEWhistory →COM1.86%$14M60.9K
22VRTXVERTEX PHARMACEUTICALS INChistory →COM1.69%$13M59.4K
23SHCSOTERA HEALTH COhistory →COM1.68%$13M551.6K
24POST HOLDINGS PARTNERING CORUNIT 99/99/99991.65%$13M1.25M
25TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS1.55%$12M1.50M
26IRWDIRONWOOD PHARMACEUTICALS INChistory →COM CL A1.40%$11M929.7K
27AVANTI ACQUISITION CORPUNIT 99/99/99991.31%$10M1.00M
28ATRAGBXATARA BIOTHERAPEUTICS INChistory →COM1.26%$10M616.5K
29WILLIAMS ROWLAND ACQUISITIONCOM · *W EXP 12/11/2021.24%$10M1.43M
30QTRXQUANTERIX CORPCOM0.97%$7M176.3K
31CUTREURCUTERA INCCOM0.95%$7M177.0K
32SRZNWSURROZEN INCCL A · *W EXP 08/01/2030.65%$5M1.17M
33MSOSADVISORSHARES TRPURE US CANNABIS0.58%$5M176.5K
34LIVANOVA PLCSHS0.52%$4M45.9K
35TECHBIO-TECHNE CORPCOM0.48%$4M7.2K
36DMTKQDERMTECH INCCOM0.46%$4M226.1K
37ABCAM PLCADS0.32%$2M103.8K
38NEXI1EURNEXIMMUNE INCCOM0.24%$2M400.0K
39NAUTNAUTILUS BIOTECHNOLOGY INCCOM0.19%$1M289.0K
40DC4DEXCOM INCCOM0.19%$1M2.7K
41OLINK HLDG ABSPONSORED ADS0.11%$836,00045.9K
42PLAYSTUDIOS INC*W EXP 06/17/2020.01%$84,000141.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.